|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Thoracic and Cardiovascular Surgery, West German Heart Center, University Hospital of Essen, Hufelandstr. 55, Essen, D-45122 Germany
(Email: heinz.jakob{at}uk-essen.de).
| Dr Jakob discloses that he has a financial relationship with JOTEC GmbH.
|
We appreciate the interest and comments by Drs Murzi and Glauber [1] regarding our article [2]. We respect their concern and would like to clarify our position.
The fate of a patent distal false lumen and its impact on long-term outcome is controversial. Uchida and colleagues [3] report a significant increase of adverse events affecting the thoracic aorta in hemi-arch procedures in contrast with frozen elephant trunk operations. Yeh and colleagues [4] confirmed these findings by multivariate analysis; a patent false lumen significantly enhances the chance of aneurysm formation in the descending aorta. Thus, the literature does not provide evidence for the best method.
Our personal experience with 26 patients presenting with life-threatening complications such as a rupture, aneurysm formation, and persisting true lumen collapse downstream within 8 months to 7 years after proximal aortic replacement for type I aortic dissection, stimulated change in our surgical concepts described in our article [2]. The following steps have been taken toward these changes:
Twenty-six of 42 patients, operated on for acute type I aortic dissection within the last 4 years, had an E-vita open hybrid graft implanted. Sixteen patients had either an ascending aorta (2 patients), hemi-arch (10 patients), or total arch replacement (4 patients) alone. This illustrates the selective indication for placement of the E-vita open stent-graft in the most difficult patient subgroup. We certainly do not recommend total arch replacement with descending stent-grafts in cases other than those previously listed. Our common line with Murzi and Glauber [1] is the intention to get the best possible result for our patients, not only in regard to hospital survival, but hopefully also for long-term freedom from events related to the thoracic aorta. Whether or not this aim will be reached is a matter of a retrospective and prospective investigation by a European multicenter study group established in 2008 to collect a large data pool within the years to come.
| References |
|---|
|
|
|---|
Related Article
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |